ARTICLE | Company News
Micromet, Tracon cancer deal
March 17, 2007 12:18 AM UTC
MITI granted Tracon (San Diego, Calif.) exclusive, worldwide rights to develop and commercialize D93 to treat cancer. MITI could receive upfront and milestone payments of more than $100 million, plus ...